Dr. Kuipers studies various aspects of medical technology and treatments that impact patient outcomes. His research includes developing gas detection systems that help identify gases for environmental and mobile applications, which is crucial for safety and monitoring. He also investigates how different storage systems for platelets, a key component in blood transfusions, can influence their quality and effectiveness, ultimately guiding medical professionals in choosing the best preparation methods for patients needing transfusions. Additionally, he is involved in creating new medications for mental health conditions like schizophrenia, focusing on minimizing side effects while maximizing treatment efficacy.
Key findings
In a study on gas detection, Dr. Kuipers found that the best microelectromechanical systems-based detector settings could identify gases effectively, but its sensitivity for carbon and methane was significantly lower than conventional methods.
His work on platelet pooling systems revealed that a specific system could maintain the quality of over 424 billion platelets for up to 9 days, vital for ensuring transfusion safety.
Research on overnight versus fresh platelet concentrates showed that overnight-stored platelets had about 460 billion platelets per unit but indicated lower quality over time, which is crucial for improving transfusion practices.
A study on automated hematology analyzers found that one model could overestimate platelet counts by more than 20%, highlighting the need for accurate measurement in patient care.
Dr. Kuipers identified new chemical compounds that showed strong binding affinity to the serotonin 5-HT1A receptor, indicating potential new treatment options for mood disorders.
Frequently asked questions
Does Dr. Kuipers study blood transfusions?
Yes, he investigates how different platelet storage and preparation methods affect the quality and effectiveness of blood transfusions.
What types of gas detection technology does Dr. Kuipers work on?
He studies miniaturized gas detectors that are essential for safety and monitoring in environmental applications, focusing on their sensitivity and performance.
Is Dr. Kuipers involved in mental health research?
Yes, he develops new medications aimed at treating mental health disorders like schizophrenia, emphasizing reduced side effects.
How can Dr. Kuipers' research benefit patients?
His findings help improve blood transfusion practices, enhance safety in gas detection, and develop better treatment options for psychiatric conditions.
What innovations has Dr. Kuipers contributed to platelet storage?
He has identified optimal pooling systems that maintain platelet quality, significant for ensuring safe and effective transfusions for patients.
Publications in plain English
Characterization of a microelectromechanical systems-based counter-current flame ionization detector.
2011
Journal of chromatography. A
Kuipers W, Müller J
Plain English This research studied a new type of gas detector used to identify small amounts of gases, focusing on how different settings affect its performance. The best results were achieved with specific conditions: using a small flame chamber, a gas flow of 2.0ml/min, and supplying oxygen at 9.4ml/min. However, the detector's ability to detect low levels of carbon and methane was found to be less effective than conventional detectors, with the minimum detectable amounts being significantly higher than usual.
Who this helps: This research aids engineers and scientists working on gas detection technology, particularly for mobile applications.
Sensitivity of a planar micro-flame ionization detector.
2010
Talanta
Kuipers W, Müller J
Plain English Researchers studied a miniaturized gas detector that uses a flame to measure different gases. They found that the sensitivity of this device increases when the size of gas molecules is smaller, and it can detect methane as effectively as larger, traditional detectors. This is important because it allows for more portable and efficient detection of gases in various applications, such as environmental monitoring or on-the-go analysis.
Who this helps: This benefits scientists and engineers who need portable gas detection tools.
Overnight or fresh buffy coat-derived platelet concentrates prepared with various platelet pooling systems.
2008
Transfusion
Dijkstra-Tiekstra MJ, Kuipers W, Setroikromo AC, de Wildt-Eggen J
Plain English This study looked at two types of platelet concentrates (the components of blood used for transfusions) made from fresh blood and blood stored overnight. It found that overnight-stored platelets had a higher count (about 460 billion platelets per unit compared to 310 billion) but also showed signs of lower quality over time, such as decreased oxygen levels and increased acidity. The findings are important because they can help medical professionals choose the best method for preparing platelets, potentially improving patient outcomes with blood transfusions.
Who this helps: This helps patients who receive blood transfusions and the doctors managing their care.
Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
2008
Transfusion
Dijkstra-Tiekstra MJ, Kuipers W, Setroikromo AC, de Wildt-Eggen J
Plain English This study looked at how different systems for collecting and storing platelets affect their quality over time. Researchers tested four types of storage systems and found that all systems maintained good platelet quality for up to 9 days, but the Baxter system could handle the largest quantity of platelets (over 424 billion) while still performing well. This is important because using the right storage system can ensure that patients receive platelets that are effective and safe for transfusions.
Who this helps: Patients needing platelet transfusions.
Platelet counting in platelet concentrates with various automated hematology analyzers.
2007
Transfusion
Dijkstra-Tiekstra MJ, Kuipers W, Setroikromo AC, de Wildt-Eggen J
Plain English This study examined how well different machines can count platelets in platelet concentrates, which are used for blood transfusions and lack red blood cells. The six analyzers tested showed that most could accurately measure platelets, but one model overestimated counts by more than 20%. It's important to ensure these machines are properly validated for counting platelets in these special samples, as precise measurements are critical for patient care.
Who this helps: This benefits patients receiving blood transfusions and the healthcare professionals who manage their treatment.
New 1-aryl-4-(biarylmethylene)piperazines as potential atypical antipsychotics sharing dopamine D(2)-receptor and serotonin 5-HT(1A)-receptor affinities.
2001
Bioorganic & medicinal chemistry letters
Feenstra RW, de Moes J, Hofma JJ, Kling H, Kuipers W +4 more
Plain English Researchers created new chemical compounds aimed at treating mental health disorders, focusing on how well they interact with certain brain receptors known to affect mood and behavior. Out of several compounds tested, one showed promise as a potential new medication for schizophrenia that may cause fewer side effects, such as movement disorders; this candidate is currently undergoing clinical trials. This is important because it could lead to better treatment options for patients with mental health conditions while minimizing uncomfortable side effects.
Who this helps: Patients with schizophrenia and related disorders.
The interaction of class B G protein-coupled receptors with their hormones.
1998
Receptors & channels
Horn F, Bywater R, Krause G, Kuipers W, Oliveira L +3 more
Plain English This study looked at a specific group of proteins called Class B G protein-coupled receptors and how they interact with hormones that can influence various diseases. The researchers used computer modeling to identify key parts of these receptors that may be crucial for binding with their hormones, finding that certain mutations in these proteins line up with known changes in their hormone partners. Understanding these interactions is important because it could lead to new treatments for diseases linked to these receptors.
Who this helps: This helps patients with diseases related to hormone imbalances.
Identification of class-determining residues in G protein-coupled receptors by sequence analysis.
1997
Receptors & channels
Kuipers W, Oliveira L, Vriend G, Ijzerman AP
Plain English This study looked at G protein-coupled receptors (GPCRs), which are important for many bodily functions because they help transmit signals in our cells. The researchers developed a new computer method to identify specific amino acids in these receptors that are crucial for their ability to bind with other molecules, finding many that are already known to be important and discovering new ones that could be targeted for further research. This is important because it can lead to better models for how these receptors work and enhance our understanding of how they interact with different substances, potentially aiding drug development.
Who this helps: This helps researchers and drug developers working on new treatments.
5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
1997
Journal of medicinal chemistry
Kuipers W, Kruse CG, van Wijngaarden I, Standaar PJ, Tulp MT +3 more
Plain English This study focused on flesinoxan, a compound that interacts with specific brain receptors, particularly the 5-HT1A receptor and the D2 receptor. Researchers created and tested various versions of flesinoxan to see how changes in its structure affected its binding to these receptors. They found that while certain parts of the compound do not directly interact with the 5-HT1A receptor, the design of flesinoxan allows it to bind more selectively to this receptor rather than the D2 receptor, which is important for developing treatments for mental health issues.
Who this helps: This helps patients with disorders like depression and anxiety who may benefit from targeted therapies.
Study of the interaction between aryloxypropanolamines and Asn386 in helix VII of the human 5-hydroxytryptamine1A receptor.
1997
Molecular pharmacology
Kuipers W, Link R, Standaar PJ, Stoit AR, Van Wijngaarden I +2 more
Plain English This study focused on how certain drugs called aryloxypropanolamines interact with a specific part of a human brain receptor known as the 5-HT1A receptor. Researchers found that a change in a particular amino acid (from Asn386 to Val) reduced the ability of these drugs to bind to the receptor, with the S-enantiomers being more affected than the R-enantiomers. This matters because it helps us understand how these drugs work in the body and could lead to better treatments that target this receptor effectively.
Who this helps: Patients who need effective treatments for conditions related to serotonin signaling, like anxiety or depression.
Recruitment and retention of psychiatrists in non-metropolitan public positions in Queensland: research on "Queensland Health's response'.
1996
The Australian and New Zealand journal of psychiatry
Emmerson B, Brown P, Whiteford H, McVie N, Kuipers W
Plain English The study looked at how Queensland Health recruited psychiatrists to work in rural areas between 1992 and 1993. Out of 15 psychiatrists, 13 provided feedback, revealing that most were experienced professionals drawn to these positions for lifestyle reasons and the professional challenge. Although the recruitment was seen as successful, issues like bureaucratic obstacles and personal reasons were significant factors that might drive them away from these jobs.
Who this helps: This benefits psychiatrists looking for opportunities in rural settings and the communities that need mental health services.
N4-unsubstituted N1-arylpiperazines as high-affinity 5-HT1A receptor ligands.
1995
Journal of medicinal chemistry
Kuipers W, van Wijngaarden I, Kruse CG, ter Horst-van Amstel M, Tulp MT +1 more
Plain English This study looked at how different chemical structures affect the ability of certain compounds, called arylpiperazines, to bind to the 5-HT1A receptor in the brain, which is important for mood regulation. The researchers found that compounds with a 2-methoxy group had the strongest binding, while those with 4-methoxy or bulky groups in certain positions did not bind as well. Several new compounds showed strong binding affinities, with some in the low-nanomolar range, indicating their potential use in treatments related to mood disorders.
Who this helps: This benefits patients with mood disorders and their doctors by identifying potential new treatment options.
A model of the serotonin 5-HT1A receptor: agonist and antagonist binding sites.
1994
Drug design and discovery
Kuipers W, Van Wijngaarden I, Ijzerman AP
Plain English This research created a detailed model of the serotonin 5-HT1A receptor, which is important for understanding how certain drugs work. The study found that different drugs known to activate (agonists) or block (antagonist) the receptor interact with specific parts of the receptor in distinct ways, particularly noting the importance of a specific amino acid known to bind various amines. This understanding is important for developing better drugs that target this receptor effectively.
Who this helps: This benefits patients who use medications targeting serotonin receptors, particularly those with mental health conditions.
Maintenance of viability and transport function after preservation of isolated rat hepatocytes in various simplified University of Wisconsin solutions.
Plain English This study looked at how well rat liver cells (hepatocytes) can be preserved using different solutions for up to 48 hours. The researchers found that the cells stayed healthy and functional for 24 hours, especially in a simplified solution that is cheaper than the commonly used University of Wisconsin solution. This is important because it means researchers can use a less expensive and effective method to keep liver cells alive for drug studies.
Who this helps: This helps researchers in pharmaceuticals and medicine who study liver function and drug treatment effects.
A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.
1987
Thrombosis and haemostasis
Koppert PW, Kuipers W, Hoegee-de Nobel B, Brommer EJ, Koopman J +1 more
Plain English This study looked at a new test that measures specific breakdown products from fibrinogen, a protein involved in blood clotting. The test is very accurate and can detect tiny amounts of these products in the blood, which is important because it helps in diagnosing conditions like blood clotting disorders. For example, it found that patients with disseminated intravascular coagulation had little to no breakdown products from fibrinogen, while those treated with streptokinase after a heart attack had high levels of these products shortly after treatment.
Who this helps: This helps doctors diagnose and manage patients with blood clotting disorders and those undergoing certain treatments.